Oxford Asset Management LLP acquired a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,097 shares of the health services provider's stock, valued at approximately $978,000.
Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. lifted its position in shares of Maximus by 79.8% during the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank acquired a new position in shares of Maximus during the fourth quarter worth about $29,000. V Square Quantitative Management LLC raised its holdings in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares during the last quarter. R Squared Ltd acquired a new position in Maximus during the fourth quarter worth $54,000. Finally, IFP Advisors Inc raised its holdings in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
MMS has been the topic of a number of recent research reports. StockNews.com cut Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a report on Thursday, January 2nd.
Get Our Latest Research Report on MMS
Maximus Stock Down 0.6 %
Shares of Maximus stock traded down $0.44 during midday trading on Thursday, reaching $66.53. 201,276 shares of the company's stock traded hands, compared to its average volume of 554,587. The company has a market cap of $3.77 billion, a price-to-earnings ratio of 14.32 and a beta of 0.68. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The company's 50 day simple moving average is $67.66 and its 200 day simple moving average is $74.14.
Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.80%. Maximus's dividend payout ratio (DPR) is 25.81%.
Insider Buying and Selling
In related news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.